Marzia Argnani

Is There Any Difference in PBPC Mobilization Between Cyclophosphamide Plus G-CSF and G-CSF Alone in Patients with Non-Hodgkin's Lymphoma?

Claudio Dazzi, Anna Cariello, Giovanni Rosti et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2000 · 48 citations

Medicine, Hematology, Oncology +16

A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization

Barbara Kopf, Ugo De Giorgi, Bernadette Vertogen et al. · Bone Marrow Transplantation · 2006 · 41 citations

Medicine, Hematology, Pharmacotherapy +14

Salvage high‐dose chemotherapy in patients with germ cell tumors

Giovanni Rosti, Ugo De Giorgi, Roberto Salvioni et al. · Cancer · 2002 · 28 citations · Full text

Medicine, Oncology, Chemotherapy +10

Peripheral blood progenitor cell (PBPC) mobilization in heavily pretreated patients with germ cell tumors: a report of 34 cases

Claudio Dazzi, Anna Cariello, Giovanni Rosti et al. · Bone Marrow Transplantation · 1999 · 16 citations

Medicine, Hematology, Oncology +13

Epirubicin + G-CSF as peripheral blood progenitor cells (PBPC) mobilising agents in breast cancer patients

Giovanni Rosti, L. Albertazzi, Patrizia Ferrante et al. · Annals of Oncology · 1995 · 12 citations

Medicine, Hematology, Oncology +17